Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

737 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients.
Caillard S, Meyer N, Solis M, Bertrand D, Jaureguy M, Anglicheau D, Ecotiere L, Buchler M, Bouvier N, Schvartz B, Rerolle JP, Heng AE, Couzi L, Duveau A, Morelon E, LeMeur Y, Golbin L, Thervet E, Benotmane I, Fafi-Kremer S. Caillard S, et al. Among authors: bertrand d. Kidney Int. 2024 Oct 28:S0085-2538(24)00730-0. doi: 10.1016/j.kint.2024.09.018. Online ahead of print. Kidney Int. 2024. PMID: 39490986
Imlifidase in Highly Sensitized Kidney Transplant Recipients With a Positive Crossmatch Against a Deceased Donor.
Kamar N, Bertrand D, Caillard S, Pievani D, Apithy MJ, Congy-Jolivet N, Chauveau B, Farce F, François A, Delas A, Olagne J, Usureau C, Taupin JL, Guidicelli GL, Couzi L. Kamar N, et al. Among authors: bertrand d. Kidney Int Rep. 2024 Jul 30;9(10):2927-2936. doi: 10.1016/j.ekir.2024.07.024. eCollection 2024 Oct. Kidney Int Rep. 2024. PMID: 39430184 Free PMC article.
Treat-to-target fixed dose rituximab retreatment versus fixed interval retreatment with disease activity-guided rituximab dose optimisation for patients with rheumatoid arthritis: study protocol for a multicentre randomised controlled superiority trial focusing on long-term disease impact (RITUXERA).
De Meyst E, Bertrand D, Joly J, Doumen M, Marchal A, Thelissen M, Neerinckx B, Westhovens R, Verschueren P. De Meyst E, et al. Among authors: bertrand d. Trials. 2024 Oct 15;25(1):681. doi: 10.1186/s13063-024-08542-7. Trials. 2024. PMID: 39407334 Free PMC article.
Fine mapping of RNA isoform diversity using an innovative targeted long-read RNA sequencing protocol with novel dedicated bioinformatics pipeline.
Aucouturier C, Soirat N, Castéra L, Bertrand D, Atkinson A, Lavolé T, Goardon N, Quesnelle C, Levilly J, Barbachou S, Legros A, Caron O, Crivelli L, Denizeau P, Berthet P, Ricou A, Boulouard F, Vaur D, Krieger S, Leman R. Aucouturier C, et al. Among authors: bertrand d. BMC Genomics. 2024 Sep 30;25(1):909. doi: 10.1186/s12864-024-10741-0. BMC Genomics. 2024. PMID: 39350015 Free PMC article.
Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal Kinetics.
Sallee M, Resseguier N, Crepin T, Bertin D, Bertrand D, Bobot M, Krummel T, Maillard N, Moussi-Frances J, Pelletier M, Poullin P, Rafat C, Robert T, Terrier B, Rostaing L, Faguer S, Jourde-Chiche N. Sallee M, et al. Among authors: bertrand d. Kidney Int Rep. 2024 Jun 27;9(9):2767-2773. doi: 10.1016/j.ekir.2024.06.031. eCollection 2024 Sep. Kidney Int Rep. 2024. PMID: 39291196 Free PMC article.
737 results